Factors associated with rebound pain after peripheral nerve block for ambulatory surgery.
Garrett S Barry, Jonathan G Bailey, Joel Sardinha...
https://pubmed.ncbi.nlm.nih.gov/33390261/Actively Recruiting
Led by Eskisehir Osmangazi University · Updated on 2026-06-12
66
Participants Needed
1
Research Sites
N/A
Total Duration
Orthopedic shoulder surgeries often lead to severe pain after the operation, especially in the first 24 to 48 hours. This research is focused on patients undergoing shoulder surgery who receive an interscalene brachial plexus block and general anesthesia. The study aims to evaluate how intravenous dexketoprofen, given after surgery, affects the occurrence and severity of rebound pain, which is a sharp pain that can happen after the nerve block wears off. Various factors such as patient age, sex, and surgical details are considered in understanding this pain. Sixty-six patients having rotator cuff repair will participate. All will receive a standard nerve block and general anesthesia, along with medications like midazolam, lidocaine, propofol, rocuronium, and remifentanil during surgery. After surgery, patients will get morphine through a controlled device and paracetamol at set times. They will be randomly assigned to one of two groups one group receives dexketoprofen at 6 and 18 hours after surgery, and the other does not receive this anti-inflammatory drug. Participants will be monitored for 24 hours after surgery. Researchers will measure pain levels at rest and during movement, the intensity and timing of rebound pain, blood pressure, oxygen levels, use of pain medication, and any complications. These observations will help assess how dexketoprofen may influence pain management following shoulder surgery with nerve block.
CONDITIONS
The Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain
Ç
Çağla Uzalp
M
Meryem Onay
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Eskisehir Osmangazi University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 24 hours
Participants undergo shoulder surgery with a nerve block and receive standard anesthesia and pain control. They are randomly assigned to receive dexketoprofen or not after surgery.
Multiple assessments during 24 hours post-surgery
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Garrett S Barry, Jonathan G Bailey, Joel Sardinha...
https://pubmed.ncbi.nlm.nih.gov/33390261/Narinder P Singh, Jeetinder K Makkar, Janeesha K Chawla...
https://pubmed.ncbi.nlm.nih.gov/38501226/Vishal Uppal, Garrett Barry, Janny X C Ke...
https://pubmed.ncbi.nlm.nih.gov/37833472/Eskisehir Osmangazi University
Lead Sponsor